SKU: WM0147 Categories: ,

Dynamin II Monoclonal Antibody

Price range: $268.00 through $328.00

SKU: WM0147-50
Enter the quantity you would like, or drag the panel to find the quantity and price that best for you
Bulk QuoteAuthorize OEM & ODM

Product details

Background:
dynamin 2(DNM2) Homo sapiens Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010],

Specifications

Size50μL/100μL
TargetDynamin II
ReactivityHuman
ApplicationsWB, IHC, IF, ELISA
MW(Calculated)98kD
MW(Observed)
Host SpeciesMouse
Isotype
Conjugate/ModificationUnmodified
Recommended Dilution RatioWB 1:500-1:2000; IHC 1:200-1:1000; ELISA 1:10000; IF 1:50-200 / Note: For IHC, we suggest antigen retrieval with TE buffer pH 9.0 (Cat#WT1004)
FormulationLiquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
PurificationAffinity purification
Storage-15°C to -25°C/1 year(Do not lower than -25°C)
Concentration
ClonalityMonoclonal
Clone Number2A2
ImmunogenPurified recombinant fragment of Dynamin II expressed in E. Coli.
SpecificityDynamin II Monoclonal Antibody detects endogenous levels of Dynamin II protein.
Gene NameDNM2
Protein NameDynamin-2
Other NameDNM2; / DYN2; / Dynamin-2
SpeciesHuman
Gene ID1785
UniprotP50570,
Species.1Mouse
Gene ID.1
Uniprot.1P39054
Species.2
Gene ID.2
Uniprot.2
Cellular LocalizationCytoplasm. Cytoplasm, cytoskeleton. Cell junction . Membrane, clathrin-coated pit . Cell junction, synapse, postsynaptic density. Cell junction, synapse. Midbody. Cell projection, phagocytic cup . Cytoplasmic vesicle, phagosome membrane; Peripheral membrane protein . Colocalizes with CTTN at the basis of filopodia in hippocampus neuron growth zones (By similarity). Microtubule-associated. Also found in the postsynaptic density of neuronal cells. Co-localizes with PIK3C3 and RAB5A to the nascent phagosome (By similarity). .
Tissue ExpressionUbiquitously expressed.
Signaling_pathwayOrganismal Systems >> Immune system >> Fc gamma R-mediated phagocytosis;Organismal Systems >> Nervous system >> Synaptic vesicle cycle;Environmental Information Processing >> Signal transduction >> Phospholipase D signaling pathway
Research Areas>>Phospholipase D signaling pathway; / >>Endocytosis; / >>Fc gamma R-mediated phagocytosis; / >>Synaptic vesicle cycle; / >>Endocrine and other factor-regulated calcium reabsorption; / >>Bacterial invasion of epithelial cells; / >>Salmonella infection
FunctionCatalytic activity:GTP + H(2)O = GDP + phosphate.,Disease:Defects in DNM2 are a cause of centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150]; also known as autosomal dominant myotubular myopathy. Centronuclear myopathies (CNMs) are congenital muscle disorders characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. CNMs comprise a wide spectrum of phenotypes, ranging from severe neonatal to mild late-onset familial forms. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.,Disease:Defects in DNM2 are the cause of Charcot-Marie-Tooth disease dominant intermediate type B (CMTDIB) [MIM:606482]. Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. CMTDIB is a form of Charcot-Marie-Tooth disease characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec.,Function:Microtubule-associated force-producing protein involved in producing microtubule bundles and able to bind and hydrolyze GTP. Most probably involved in vesicular trafficking processes, in particular endocytosis.,similarity:Belongs to the dynamin family.,similarity:Contains 1 GED domain.,similarity:Contains 1 PH domain.,subcellular location:Microtubule-associated. Also found in the postsynaptic density of neuronal cells.,subunit:Interacts with MYOF (By similarity). Interacts with SHANK1, SHANK2, SH3BP4 and NOSTRIN.,tissue specificity:Ubiquitously expressed.,
Please login to post questions
Back to Top
Product has been added to your cart